Dates and Locations
→ Saturday, November 2, 2019 | Newport Beach, CA
→ Saturday, November 9, 2019 | Philadelphia, PA
→ Saturday, November 16, 2019 | Miami, FL
→ Saturday, December 7, 2019 | Washington, DC
Multiple sclerosis (MS) is a chronic, often disabling disease that attacks the central nervous system. The management of patients with MS is highly complex, and the development of disease-modifying therapies (DMTs) has dramatically altered the treatment paradigm. Clinicians need to be updated on new evidence-based recommendations on the use of DMTs from the American Academy of Neurology Guidelines released in 2018. Another important aspect of caring for patients with MS is communication. Patients must be not only educated about their disease and treatment options, but also engaged in conversations about their risk tolerance, quality of life—including symptoms that they are experiencing—and any concerns they may have regarding their care. Shared decision-making is a model of two-way communication between a patient and a provider with established ability to improve a patient’s satisfaction of care. In this CME/CNE activity, MS Forum® VI, current treatment guidelines, gender-based issues, environmental factors, and comorbidities in MS will be discussed alongside the safety, efficacy, and use of current DMTs. In addition, the program will include rapid TED-like didactic presentations, video segments of a patient’s perspective of MS, and a rapid-fire panel addressing controversial topics in MS.